- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-28-0017302

Elisan Pharma LLP
About Elisan Pharma LLP
Data last updated:
Elisan Pharma LLP is a limited liability partnership (LLP) based in Ratnagiri, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 01 December 2021 and has been in existence for over 5 years.
The LLP is registered with the Registrar of Companies (ROC), Pune, under LLPIN AAZ-7159. Its GSTIN is 27AAJFE3873C1ZG (Maharashtra).
The LLP has a total obligation of contribution of ₹1 Cr. It is led by designated partners Alfaraz Ashraf Kapade and Ashraf Abdulrahiman Kapade.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at H.No. 1631 Plot No. X 28 MIDC Mirjole, Ratnagiri, Maharashtra, India – 415612.
As per MCA filings, the LLP has open charges of ₹4.95 Cr on record.
Elisan Pharma LLP is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-28-0017302).
Company details
Recognitions & Rankings of Elisan Pharma
Contact details
Elisan Pharma LLP's registered office is in Ratnagiri, Maharashtra.
- Registered AddressH.No. 1631 Plot No. X 28 MIDC Mirjole, Ratnagiri, Maharashtra, India – 415612
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Elisan Pharma LLP
FY 2025 filings availableFinancial Statement Summary
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Income and Expenditure | ||||
| Turnover | ||||
| Other Income | ||||
| Total Income | ||||
| Purchases and Direct Costs | ||||
| Personnel Expenses | ||||
| Administrative Expenses | ||||
| Interest | ||||
| Depreciation | ||||
| Total Expenses | ||||
| Profit Before Tax | ||||
| Tax | ||||
| Profit After Tax | ||||
| Profit Transferred to Partners | ||||
| Assets and Liabilities | ||||
| Partners' Contribution | ||||
| Reserves and Surplus | ||||
| Secured Loans | ||||
| Unsecured Loans | ||||
| Trade Payables | ||||
| Other Liabilities and Provisions | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Loans and Advances | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| Net Profit Margin | ||||
| Return on Partners' Funds | ||||
| Return on Assets | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Debt to Partners' Funds | ||||
| Interest Coverage | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Turnover Growth | ||||
| Profit Growth | ||||
To see the full financial statements and ratios of Elisan Pharma LLP, buy the company report.
Designated partners of Elisan Pharma LLP
Elisan Pharma has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Alfaraz Ashraf Kapade | Designated Partner | 01 Dec 2021 | 4 Years 11 Months | Current |
| Ashraf Abdulrahiman Kapade | Designated Partner | 01 Dec 2021 | 4 Years 11 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Feb 2022 | 100698635 | State Bank of India | ₹4.95 Cr | Open |
To see the full charge records of Elisan Pharma LLP, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Elisan Pharma LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Elisan Pharma LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Elisan Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAJFE3873C1ZG | Maharashtra | Active | 31 Dec 2021 |
To see the full GST registrations and return filing status of Elisan Pharma LLP, buy the company report.
Recent activity
Elisan Pharma LLP has 2 designated partner changes on record since 2021: 2 appointments. The latest: Alfaraz Ashraf Kapade was appointed as Designated Partner on 01 Dec 2021.
Frequently asked questions
Elisan Pharma is an active limited liability partnership based in Ratnagiri, Maharashtra, India. The LLP works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 01 December 2021 (5+ years old) and is registered under LLPIN AAZ-7159.
Elisan Pharma has 2 current designated partners:
- Alfaraz Ashraf Kapade - Designated Partner
- Ashraf Abdulrahiman Kapade - Designated Partner
The latest financial statements of Elisan Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Elisan Pharma is 27AAJFE3873C1ZG, registered in Maharashtra.
The LLPIN (Limited Liability Partnership Identification Number) of Elisan Pharma is AAZ-7159. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Elisan Pharma was incorporated on 01 December 2021, making it 5+ years old. It is registered with the Registrar of Companies, Pune.
Alfaraz Ashraf Kapade was appointed as Designated Partner on 01 Dec 2021. Ashraf Abdulrahiman Kapade was appointed as Designated Partner on 01 Dec 2021.
Yes, Elisan Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-MH-28-0017302).
The registered office of Elisan Pharma is at H.No. 1631 Plot No. X 28 MIDC Mirjole, Ratnagiri, Maharashtra, India – 415612.
Elisan Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

